Complications of Cancer TreatmentICD-10-CM CodeICD-10-CM DescriptionD61.1Drug-induced aplastic anemia (aplastic anemia due to antineoplastic chemotherapy)D61.810Antineoplastic chemotherapy induced pancytopeniaD64.81Anemia due to antineoplastic chemotherapyD70.1Agranulocytosis secondary to cancer chemotherapy19 more rows
1 for Encounter for antineoplastic chemotherapy and immunotherapy is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
The ICD-10-CM guideline states: When admission/encounter is for management of an anemia associated with the malignancy, and the treatment is only for anemia, the appropriate code for the malignancy is sequenced as the principal or first-listed diagnosis followed by code D63. 0, Anemia in neoplastic disease.
ICD-10-CM Code for Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter T45. 1X5A.
What are antineoplastic drugs? Antineoplastic drugs are medications used to treat cancer. Other names for antineoplastic drugs are anticancer, chemotherapy, chemo, cytotoxic, or hazardous drugs.
D64. 81 - Anemia due to antineoplastic chemotherapy | ICD-10-CM.
Definition. Anemia (NOS) is a decrease in the number of red blood cells. Many cancer patients develop anemia due to the cancer and/or cancer therapy. This condition may be referred to as Anemia in neoplastic disease or anemia of chronic disorders. The anemia by itself is not reportable.
Z85. 3 can be billed as a primary diagnosis if that is the reason for the visit, but follow up after completed treatment for cancer should coded as Z08 as the primary diagnosis.
11 or Z51. 12 is the only diagnosis on the line, then the procedure or service will be denied because this diagnosis should be assigned as a secondary diagnosis. When the Primary, First-Listed, Principal or Only diagnosis code is a Sequela diagnosis code, then the claim line will be denied.
810 for Antineoplastic chemotherapy induced pancytopenia is a medical classification as listed by WHO under the range - Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism .
1X5 for Adverse effect of antineoplastic and immunosuppressive drugs is a medical classification as listed by WHO under the range - Injury, poisoning and certain other consequences of external causes .
G62. 0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM G62.
Z51. 11 is attached to the billing for the administration of chemotherapy so would not be used by the provider when the patient is going to a hospital-owned infusion center.
Antineoplastic chemotherapy drugs are a type of medication that doctors use to treat cancer. They contain chemicals that kill cells that rapidly divide, including cancer cells.
Background: Chemotherapy administration services (CPT codes 96400, 96408 to 96425, 96520 and 96530) , therapeutic or diagnostic infusions (excluding chemotherapy) (CPT codes 90780 to 90781), and drug injection codes (90782 to 90788) are paid under the Medicare physician fee schedule.
ICD-10 Code for Other long term (current) drug therapy- Z79. 899- Codify by AAPC.
If this is your first visit, be sure to check out the FAQ & read the forum rules.To view all forums, post or create a new thread, you must be an AAPC Member.If you are a member and have already registered for member area and forum access, you can log in by clicking here.If you've forgotten your username or password use our password reminder tool.
D50-D89 - Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism. D60-D64 - Aplastic and other anemias and other bone marrow failure syndromes. D64 - Other anemias. D64.8 - Other specified anemias. D64.81 - Anemia due to antineoplastic chemotherapy; D64.89 - Other specified anemias
Appendix A: ICD-10-CM Official Guidelines for Coding and Reporting* These guidelines, developed by the Centers for Medicare and Medicaid Services and the National Center for Health Statistics are a set of rules developed to assist medical coders in assigning the appropriate codes.The guidelines are based on the coding and sequencing instructions from the Tabular List and the Alphabetic Index ...
Z92.89 is a billable diagnosis code used to specify a medical diagnosis of personal history of other medical treatment. The code Z92.89 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.
only the code for pancytopenia (D61.81-) should be assigned
assign code T45.515-, Adverse effect of anticoagulant, or code T45.525- , Adverse effect of antithrombotic drugs, to indicate any adverse effect of an administered drug, with code D68.32, Hemorrhagic disorder due to extrinsic circulating anticoagulants
D61.1, Drug-induced aplastic anemia, with an additional code to identify the adverse effect of a drug (T36-T50), and with a fifth or sixth character 5
Code first the underlying chronic disease, followed by code D63.8.
Code first the underlying chronic kidney disease (CKD) with a code from category N18 to indicate the stage of CKD, and code D63.1.
not assigned for hemorrhagic disorder due to extrinsic circulating anticoagulants; it is only assigned when the physician specifically documents a diagnosis of hemorrhagic disorder due to intrinsic circulating anticoagulants.
a prolonged bleeding time is an expected result, and therefore code R79.1 is not assigned.
D64.81 is a valid billable ICD-10 diagnosis code for Anemia due to antineoplastic chemotherapy . It is found in the 2021 version of the ICD-10 Clinical Modification (CM) and can be used in all HIPAA-covered transactions from Oct 01, 2020 - Sep 30, 2021 .
DO NOT include the decimal point when electronically filing claims as it may be rejected. Some clearinghouses may remove it for you but to avoid having a rejected claim due to an invalid ICD-10 code, do not include the decimal point when submitting claims electronically. See also:
Note : Here neoplasm should be coded primary as per the code first note with D63.0
Symptoms and diagnosis: All types of anemia has similar symptoms like dizziness, pale skin, light-headedness, fast heart beat, shortness of breath. As a part of confirming the diagnosis doctor may ask your personal and family history and also do a Physical exam and blood test CBC (complete blood count).
Anemia can occur due to many reasons such as blood loss, any other disease, during pregnancy, nutrition deficiency, drug induced and many more. So, there are plenty of Anemia ICD 10 codes and will discuss later on the same.
Types of Anemia: We will see few types of anemia which are frequently seen in medical records. Iron deficiency anemia –Iron is needed in blood to make hemoglobin. Iron deficiency anemia occurs when there is very low amount of iron in blood. Mostly this can happen in woman due to heavy menstruation.
O90.81 – Postpartum Anemia, this is applicable only in case of anemia not pre-existing prior to delivery
There are plenty of ICD 10 codes for anemia depending on the cause. As it is not possible to mention all the codes here, just given a screenshot below on how to search the code through ICD-10 CM manual index.
Blood loss anemia – One can become anemic due to severe blood loss. Once the cause is corrected that person becomes normal. This is termed as acute blood loss anemia. But sometimes, for example, in case of stomach ulcers, occult blood can happen for a long time. This chronic blood loss can lead to anemia which is called chronic blood loss anemia.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion '), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous such as tumors in different quadrants of the same breast, codes for each site should be assigned.
When a primary malignancy has been previously excised or eradicated from its site and there is no further treatment directed to that site and there is no evidence of any existing primary malignancy at that site, a code from category Z85, Personal history of malignant neoplasm, should be used to indicate the former site of the malignancy. Any mention of extension, invasion, or metastasis to another site is coded as a secondary malignant neoplasm to that site. The secondary site may be the principal or first-listed with the Z85 code used as a secondary code.
The neoplasm table in the Alphabetic Index should be referenced first. However, if the histological term is documented, that term should be referenced first, rather than going immediately to the Neoplasm Table, in order to determine which column in the Neoplasm Table is appropriate. Alphabetic Index to review the entries under this term and the instructional note to “see also neoplasm, by site, benign.” The table provides the proper code based on the type of neoplasm and the site. It is important to select the proper column in the table that corresponds to the type of neoplasm. The Tabular List should then be referenced to verify that the correct code has been selected from the table and that a more specific site code does not exist.
Chapter 2 of the ICD-10-CM contains the codes for most benign and all malignant neoplasms. Certain benign neoplasms , such as prostatic adenomas, may be found in the specific body system chapters. To properly code a neoplasm, it is necessary to determine from the record if the neoplasm is benign, in-situ, malignant, or of uncertain histologic behavior. If malignant, any secondary ( metastatic) sites should also be determined.
When a pregnant woman has a malignant neoplasm, a code from subcategory O9A.1 -, malignant neoplasm complicating pregnancy, childbirth, and the puerperium, should be sequenced first, followed by the appropriate code from Chapter 2 to indicate the type of neoplasm. Encounter for complication associated with a neoplasm.
When the reason for admission/encounter is to determine the extent of the malignancy, or for a procedure such as paracentesis or thoracentesis, the primary malignancy or appropriate metastatic site is designated as the principal or first-listed diagnosis, even though chemotherapy or radiotherapy is administered.
When a patient is admitted because of a primary neoplasm with metastasis and treatment is directed toward the secondary site only , the secondary neoplasm is designated as the principal diagnosis even though the primary malignancy is still present .
When a patient is admitted for the purpose of radiotherapy, immunotherapy or chemotherapy and develops complications such as uncontrolled nausea and vomiting or dehydration, the principal or first-listed diagnosis is Z51.0, Encounter for antineoplastic radiation therapy , or Z51.11, Encounter for antineoplastic chemotherapy, or Z51.12, Encounter for antineoplastic immunotherapy followed by any codes for the complications.
Assign first the appropriate code from category T86.-, Complications of transplanted organs and tissue, followed by code C80.2, Malignant neoplasm associated with transplanted organ. Use an additional code for the specific malignancy. Resources:
When a primary malignancy has been previously excised or eradicated from its site and there is no further treatment directed to that site and there is no evidence of any existing primary malignancy, a code from category Z85, Personal history of malignant neoplasm, should be used to indicate the former site of the malignancy. Any mention of extension, invasion, or metastasis to another site is coded as a secondary malignant neoplasm to that site. The secondary site may be the principal or first-listed with the Z85 code used as a secondary code.
When an episode of care involves the surgical removal of a neoplasm, primary or secondary site, followed by adjunct chemotherapy or radiation treatment during the same episode of care, the code for the neoplasm should be assigned as principal or first-listed diagnosis.
When a patient is admitted because of a primary neoplasm with metastasis and treatment is directed toward the secondary site only , the secondary neoplasm is designated as the principal diagnosis even though the primary malignancy is still present .
When the admission/encounter is for treatment of a complication resulting from a surgical procedure, designate the complication as the principal or first-listed diagnosis if treatment is directed at resolving the complication.
Anemia due to antineoplastic chemotherapy 1 D64.81 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 2 The 2021 edition of ICD-10-CM D64.81 became effective on October 1, 2020. 3 This is the American ICD-10-CM version of D64.81 - other international versions of ICD-10 D64.81 may differ.
The 2022 edition of ICD-10-CM D64.81 became effective on October 1, 2021.